Talk:Evidence based assessment/Generalized anxiety disorder (assessment portfolio)

From Wikiversity
Jump to navigation Jump to search

General comments 03/8/18[edit]

Demographic information[edit]

Last few studies are much older (late 90s), are they as useful?

Diagnosis[edit]

Could add ICD criteria Could add DSM-IV to 5 changes Maybe collapse less important/less ideal measures (eg: based on DSM-IV, not free measures) Maybe have references that indicate certain measures have good reliability and validity; currently only based on book Maybe link to explanations for reliability/validity information (HAVE A SEPARATE PAGE FOR ALL THE TERMS) If measures has PDF, link to home page of that measure instead of direct PDF; allows for linkage to multiple versions "Best recommended for" column should be deleted if it's not going to be fleshed out

Treatment[edit]

Is this the right medication that should be listed? Specific dosage seems a lot and not applicable

Process and outcome measures[edit]

Hard to explain table, could use some explaining


To-dos[edit]

Drop suggestions and next to-dos in their respective sections. For each section, please add four tildes (~~~~). This is to add a timestamp and your username next to your suggestion.

Demographic information[edit]

Dimensions of Sexual Orientation and the Prevalence of Mood and Anxiety Disorders in the United States: Found an article that provides info about prevalence of anxiety disorder for LGBTQs (Bostwick et al. , 2010)--Kateforay (discusscontribs) 23:39, 1 March 2018 (UTC)

A Cross-Ethnic Comparison of Lifetime Prevalence Rates of Anxiety Disorders: Found a paper that uses national survey data to determine the lifetime prevalence of anxiety disorder of White Americans, African Americans, Asian Americans, and Hispanic Americans (Asnaani et al., 2010)--Kateforay (discusscontribs) 23:25, 1 March 2018 (UTC)


Diagnosis[edit]

Hard to find SCID diagnosis measures in PDF form that are consistent

Consider adding the GAD-7 Scale (https://www.integration.samhsa.gov/clinical-practice/GAD708.19.08Cartwright.pdf) Emileekruchten (discusscontribs) 22:32, 1 March 2018 (UTC)

Spanish Version for GAD-7 Scale as well (http://www.coloradohealthpartnerships.com/provider/integrated/GAD7-Spanish.pdf) Emileekruchten (discusscontribs) 22:45, 1 March 2018 (UTC)

Found screening scales called the K10 and K6 scales (aka Kessler Psychological Stress Scale) used by NHIS. It is available in a variety of different languages https://www.hcp.med.harvard.edu/ncs/k6_scales.php --Kateforay (discusscontribs) 23:12, 1 March 2018 (UTC)

Treatment[edit]

Consider adding exposure therapy (https://www.sciencedirect.com/science/article/pii/S088761850700103X) and modeling therapy to "Behavioral Interventions" Emileekruchten (discusscontribs) 23:36, 1 March 2018 (UTC)

There are no references for "Combination Treatment"; add one or delete it Emileekruchten (discusscontribs) 23:38, 1 March 2018 (UTC)

Found a new type of treatment for GAD: Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. https://www.ncbi.nlm.nih.gov/pubmed/7649463 There was a significant reduction in symptoms and long-term effects --Kateforay (discusscontribs) 23:25, 1 March 2018 (UTC)

Process and outcome measures[edit]

Removed: Recommended diagnostic instruments Anxiety Disorders Interview Schedule for Children/Parents (ADIS-C/P) Almost all available publications so far were evaluating the use of ADIS-C/P under the DSM-IV framework. Within those studies, ADIS-C/P demonstrated decent convergent and discriminant validity with other self-report anxiety measures such as the Multidimensional Anxiety Scale for Children (MASC; March et al., 1997; Wood et al., 2002). However, it is worth noting that MASC predicts GAD poorly (AUC ranges from .55 - .65; Van Gastel et al., 2008).

In addition to its concurrent validity, ADIS-C/P also demonstrated high interrater reliability between parents and children for general anxiety disorder (kappa = .8; Lyneham et al., 2007).